Logo image of IBP

INSTALLED BUILDING PRODUCTS (IBP) Stock Fundamental Analysis

NYSE:IBP - New York Stock Exchange, Inc. - US45780R1014 - Common Stock - Currency: USD

206.5  +4.21 (+2.08%)

After market: 206.5 0 (0%)

Fundamental Rating

6

IBP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Household Durables industry. IBP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IBP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year IBP was profitable.
In the past year IBP had a positive cash flow from operations.
IBP had positive earnings in each of the past 5 years.
In the past 5 years IBP always reported a positive cash flow from operatings.
IBP Yearly Net Income VS EBIT VS OCF VS FCFIBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

IBP has a better Return On Assets (12.31%) than 90.48% of its industry peers.
IBP has a Return On Equity of 37.24%. This is amongst the best in the industry. IBP outperforms 96.83% of its industry peers.
The Return On Invested Capital of IBP (16.53%) is better than 92.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBP is significantly above the industry average of 10.08%.
Industry RankSector Rank
ROA 12.31%
ROE 37.24%
ROIC 16.53%
ROA(3y)12.44%
ROA(5y)10.54%
ROE(3y)39.34%
ROE(5y)35.39%
ROIC(3y)16.81%
ROIC(5y)14.72%
IBP Yearly ROA, ROE, ROICIBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

IBP's Profit Margin of 8.39% is fine compared to the rest of the industry. IBP outperforms 66.67% of its industry peers.
IBP's Profit Margin has improved in the last couple of years.
IBP has a better Operating Margin (12.67%) than 80.95% of its industry peers.
In the last couple of years the Operating Margin of IBP has grown nicely.
IBP has a better Gross Margin (33.54%) than 68.25% of its industry peers.
IBP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.67%
PM (TTM) 8.39%
GM 33.54%
OM growth 3Y10.99%
OM growth 5Y10.18%
PM growth 3Y13.07%
PM growth 5Y14.1%
GM growth 3Y4.13%
GM growth 5Y3.29%
IBP Yearly Profit, Operating, Gross MarginsIBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

7

2. Health

2.1 Basic Checks

IBP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IBP has less shares outstanding than it did 1 year ago.
IBP has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, IBP has an improved debt to assets ratio.
IBP Yearly Shares OutstandingIBP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IBP Yearly Total Debt VS Total AssetsIBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

IBP has an Altman-Z score of 5.57. This indicates that IBP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.57, IBP belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
The Debt to FCF ratio of IBP is 3.38, which is a good value as it means it would take IBP, 3.38 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.38, IBP is doing good in the industry, outperforming 71.43% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that IBP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.28, IBP is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.38
Altman-Z 5.57
ROIC/WACC1.99
WACC8.3%
IBP Yearly LT Debt VS Equity VS FCFIBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

IBP has a Current Ratio of 2.89. This indicates that IBP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.89, IBP is in line with its industry, outperforming 58.73% of the companies in the same industry.
IBP has a Quick Ratio of 2.31. This indicates that IBP is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of IBP (2.31) is better than 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 2.31
IBP Yearly Current Assets VS Current LiabilitesIBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.17% over the past year.
Measured over the past years, IBP shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.81% on average per year.
Looking at the last year, IBP shows a small growth in Revenue. The Revenue has grown by 4.30% in the last year.
IBP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.24% yearly.
EPS 1Y (TTM)2.17%
EPS 3Y27.6%
EPS 5Y27.81%
EPS Q2Q%-15.79%
Revenue 1Y (TTM)4.3%
Revenue growth 3Y14.32%
Revenue growth 5Y14.24%
Sales Q2Q%-1.17%

3.2 Future

The Earnings Per Share is expected to grow by 0.26% on average over the next years.
The Revenue is expected to grow by 1.54% on average over the next years.
EPS Next Y-13.51%
EPS Next 2Y-3.1%
EPS Next 3Y0.26%
EPS Next 5YN/A
Revenue Next Year-2.85%
Revenue Next 2Y0.38%
Revenue Next 3Y1.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IBP Yearly Revenue VS EstimatesIBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
IBP Yearly EPS VS EstimatesIBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.07 indicates a rather expensive valuation of IBP.
IBP's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.82, IBP is valued a bit cheaper.
With a Price/Forward Earnings ratio of 19.60, IBP is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IBP is valued a bit more expensive than the industry average as 63.49% of the companies are valued more cheaply.
IBP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.07
Fwd PE 19.6
IBP Price Earnings VS Forward Price EarningsIBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IBP is valued a bit more expensive than 61.90% of the companies in the same industry.
IBP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.91
EV/EBITDA 12.99
IBP Per share dataIBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The excellent profitability rating of IBP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y-3.1%
EPS Next 3Y0.26%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.71%, IBP is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.25, IBP has a dividend in line with its industry peers.
With a Dividend Yield of 0.71, IBP pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

IBP has been paying a dividend for over 5 years, so it has already some track record.
IBP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
IBP Yearly Dividends per shareIBP Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

35.19% of the earnings are spent on dividend by IBP. This is a low number and sustainable payout ratio.
DP35.19%
EPS Next 2Y-3.1%
EPS Next 3Y0.26%
IBP Yearly Income VS Free CF VS DividendIBP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IBP Dividend Payout.IBP Dividend Payout, showing the Payout Ratio.IBP Dividend Payout.PayoutRetained Earnings

INSTALLED BUILDING PRODUCTS

NYSE:IBP (8/1/2025, 8:04:00 PM)

After market: 206.5 0 (0%)

206.5

+4.21 (+2.08%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners98.27%
Inst Owner Change0.19%
Ins Owners2.08%
Ins Owner Change0.26%
Market Cap5.70B
Analysts68.75
Price Target195.01 (-5.56%)
Short Float %8.96%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend3.02
Dividend Growth(5Y)N/A
DP35.19%
Div Incr Years3
Div Non Decr Years3
Ex-Date06-13 2025-06-13 (0.37)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.02%
Min EPS beat(2)-5.94%
Max EPS beat(2)-0.1%
EPS beat(4)1
Avg EPS beat(4)-2.21%
Min EPS beat(4)-6.52%
Max EPS beat(4)3.71%
EPS beat(8)5
Avg EPS beat(8)4.72%
EPS beat(12)9
Avg EPS beat(12)7.19%
EPS beat(16)11
Avg EPS beat(16)7.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.41%
Min Revenue beat(2)-2.64%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)-0.18%
Revenue beat(8)2
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)1.2%
Revenue beat(16)8
Avg Revenue beat(16)1.44%
PT rev (1m)1.4%
PT rev (3m)-3.53%
EPS NQ rev (1m)-0.64%
EPS NQ rev (3m)-10.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.96%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)-2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE 19.07
Fwd PE 19.6
P/S 1.94
P/FCF 21.91
P/OCF 16.42
P/B 8.63
P/tB N/A
EV/EBITDA 12.99
EPS(TTM)10.83
EY5.24%
EPS(NY)10.54
Fwd EY5.1%
FCF(TTM)9.42
FCFY4.56%
OCF(TTM)12.57
OCFY6.09%
SpS106.2
BVpS23.93
TBVpS-1.51
PEG (NY)N/A
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 37.24%
ROCE 22.45%
ROIC 16.53%
ROICexc 20.17%
ROICexgc 41.86%
OM 12.67%
PM (TTM) 8.39%
GM 33.54%
FCFM 8.87%
ROA(3y)12.44%
ROA(5y)10.54%
ROE(3y)39.34%
ROE(5y)35.39%
ROIC(3y)16.81%
ROIC(5y)14.72%
ROICexc(3y)20.93%
ROICexc(5y)18.7%
ROICexgc(3y)44.39%
ROICexgc(5y)40.56%
ROCE(3y)22.83%
ROCE(5y)20%
ROICexcg growth 3Y9.03%
ROICexcg growth 5Y8.59%
ROICexc growth 3Y14.62%
ROICexc growth 5Y9.03%
OM growth 3Y10.99%
OM growth 5Y10.18%
PM growth 3Y13.07%
PM growth 5Y14.1%
GM growth 3Y4.13%
GM growth 5Y3.29%
F-Score5
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.38
Debt/EBITDA 1.78
Cap/Depr 84.06%
Cap/Sales 2.97%
Interest Coverage 8.66
Cash Conversion 73.12%
Profit Quality 105.77%
Current Ratio 2.89
Quick Ratio 2.31
Altman-Z 5.57
F-Score5
WACC8.3%
ROIC/WACC1.99
Cap/Depr(3y)66.99%
Cap/Depr(5y)58.99%
Cap/Sales(3y)2.31%
Cap/Sales(5y)2.17%
Profit Quality(3y)105.43%
Profit Quality(5y)110.6%
High Growth Momentum
Growth
EPS 1Y (TTM)2.17%
EPS 3Y27.6%
EPS 5Y27.81%
EPS Q2Q%-15.79%
EPS Next Y-13.51%
EPS Next 2Y-3.1%
EPS Next 3Y0.26%
EPS Next 5YN/A
Revenue 1Y (TTM)4.3%
Revenue growth 3Y14.32%
Revenue growth 5Y14.24%
Sales Q2Q%-1.17%
Revenue Next Year-2.85%
Revenue Next 2Y0.38%
Revenue Next 3Y1.54%
Revenue Next 5YN/A
EBIT growth 1Y-2.72%
EBIT growth 3Y26.89%
EBIT growth 5Y25.87%
EBIT Next Year9.51%
EBIT Next 3Y6.63%
EBIT Next 5YN/A
FCF growth 1Y2.72%
FCF growth 3Y35.39%
FCF growth 5Y28.09%
OCF growth 1Y14.43%
OCF growth 3Y34.96%
OCF growth 5Y22.53%